These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 30026834)

  • 1. Modified CLIP score with the albumin-bilirubin grade retains prognostic value in HBV-related hepatocellular carcinoma patients treated with trans-catheter arterial chemoembolization therapy.
    Cai XR; Chen ZH; Liu MM; Lin JX; Zhang XP; Chen J; Lin Q; Ma XK; Wen JY; Xie SD; Wu XY; Dong M
    J Cancer; 2018; 9(13):2380-2388. PubMed ID: 30026834
    [No Abstract]   [Full Text] [Related]  

  • 2. The Predictive Value of Albumin-to-Alkaline Phosphatase Ratio for Overall Survival of Hepatocellular Carcinoma Patients Treated with Trans-Catheter Arterial Chemoembolization Therapy.
    Chen ZH; Zhang XP; Cai XR; Xie SD; Liu MM; Lin JX; Ma XK; Chen J; Lin Q; Dong M; Wu XY; Wen JY; Xu RH
    J Cancer; 2018; 9(19):3467-3478. PubMed ID: 30310503
    [No Abstract]   [Full Text] [Related]  

  • 3. Modified CLIP with objective liver reserve assessment retains prognosis prediction for patients with advanced hepatocellular carcinoma.
    Shao YY; Liu TH; Lee YH; Hsu CH; Cheng AL
    J Gastroenterol Hepatol; 2016 Jul; 31(7):1336-41. PubMed ID: 26860846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of albumin-bilirubin grade versus Child-Pugh score in predicting the outcome of transarterial chemoembolization for hepatocellular carcinoma using time-dependent ROC.
    Zhao S; Zhang T; Li H; Wang M; Xu K; Zheng D; Du X; Liu L
    Ann Transl Med; 2020 Apr; 8(8):538. PubMed ID: 32411761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incorporating albumin-bilirubin grade into the cancer of the liver Italian program system for hepatocellular carcinoma.
    Chan AW; Chong CC; Mo FK; Wong J; Yeo W; Johnson PJ; Yu S; Lai PB; Chan AT; To KF; Chan SL
    J Gastroenterol Hepatol; 2017 Jan; 32(1):221-228. PubMed ID: 27257086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between Child-Pugh score and Albumin-Bilirubin grade in the prognosis of patients with HCC after liver resection using time-dependent ROC.
    Zhao S; Wang M; Yang Z; Tan K; Zheng D; Du X; Liu L
    Ann Transl Med; 2020 Apr; 8(8):539. PubMed ID: 32411762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Modified Child-pugh (MCP), Albumin-bilirubin (ALBI), and Child-pugh (CP) score for predicting of survival in Hepatocellular Carcinoma Patients Treated with Transcatheter Arterial Chemoembolization.
    Liu Y; Cheng C; Zhou H; Hu S; Wang H; Xie Q; Lei L; Wang P; Liu G; Hu H
    Bull Cancer; 2021 Oct; 108(10):931-939. PubMed ID: 34247763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Albumin-bilirubin index and platelet-albumin-bilirubin index contribute to identifying survival benefit candidates in patients with hepatocellular carcinoma and Child-Pugh grade A undergoing transcatheter arterial chemoembolization with sorafenib treatment.
    Hu K; Yuan J; Tang B; Zhang F; Lu S; Chen R; Zhang L; Ren Z; Yin X
    Ann Transl Med; 2021 Feb; 9(3):237. PubMed ID: 33708864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation and prognostic value of EZ-ALBI score in patients with intermediate-stage hepatocellular carcinoma treated with trans-arterial chemoembolization.
    Ananchuensook P; Sriphoosanaphan S; Suksawatamnauy S; Siripon N; Pinjaroen N; Geratikornsupuk N; Kerr SJ; Thanapirom K; Komolmit P
    BMC Gastroenterol; 2022 Jun; 22(1):295. PubMed ID: 35701739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation and ranking of seven staging systems of hepatocellular carcinoma.
    Chen ZH; Hong YF; Lin J; Li X; Wu DH; Wen JY; Chen J; Ruan DY; Lin Q; Dong M; Wei L; Wang TT; Lin ZX; Ma XK; Wu XY; Xu R
    Oncol Lett; 2017 Jul; 14(1):705-714. PubMed ID: 28693224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of albumin-bilirubin grade for evaluation of prognosis of 2584 Japanese patients with hepatocellular carcinoma.
    Hiraoka A; Kumada T; Michitaka K; Toyoda H; Tada T; Ueki H; Kaneto M; Aibiki T; Okudaira T; Kawakami T; Kawamura T; Yamago H; Suga Y; Miyamoto Y; Tomida H; Azemoto N; Mori K; Miyata H; Ninomiya T; Kawasaki H
    J Gastroenterol Hepatol; 2016 May; 31(5):1031-6. PubMed ID: 26647219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver Function Assessment Using Albumin-Bilirubin Grade for Patients with Very Early-Stage Hepatocellular Carcinoma Treated with Radiofrequency Ablation.
    Oh IS; Sinn DH; Kang TW; Lee MW; Kang W; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
    Dig Dis Sci; 2017 Nov; 62(11):3235-3242. PubMed ID: 28983724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between Child-Pugh Score and albumin-bilirubin grade in patients treated with the combination therapy of transarterial chemoembolization and sorafenib for hepatocellular carcinoma.
    Wang Z; Fan Q; Wang M; Wang E; Li H; Liu L
    Ann Transl Med; 2020 Apr; 8(8):537. PubMed ID: 32411760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applicability of albumin-bilirubin-based Japan integrated staging score in hepatitis B-associated hepatocellular carcinoma.
    Chan AW; Chong CC; Mo FK; Wong J; Yeo W; Johnson PJ; Yu S; Lai PB; Chan AT; To KF; Chan SL
    J Gastroenterol Hepatol; 2016 Oct; 31(10):1766-1772. PubMed ID: 26992142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic Function during Repeated TACE Procedures and Prognosis after Introducing Sorafenib in Patients with Unresectable Hepatocellular Carcinoma: Multicenter Analysis.
    Hiraoka A; Kumada T; Kudo M; Hirooka M; Koizumi Y; Hiasa Y; Tajiri K; Toyoda H; Tada T; Ochi H; Joko K; Shimada N; Deguchi A; Ishikawa T; Imai M; Tsuji K; Michitaka K;
    Dig Dis; 2017; 35(6):602-610. PubMed ID: 29040999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of albumin-bilirubin grade on survival in patients with hepatocellular carcinoma who received sorafenib: An analysis using time-dependent receiver operating characteristic.
    Tada T; Kumada T; Toyoda H; Tsuji K; Hiraoka A; Michitaka K; Deguchi A; Ishikawa T; Imai M; Ochi H; Joko K; Shimada N; Tajiri K; Hirooka M; Koizumi Y; Hiasa Y; Tanaka J
    J Gastroenterol Hepatol; 2019 Jun; 34(6):1066-1073. PubMed ID: 30549320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival Analysis Using Albumin-Bilirubin (ALBI) Grade for Patients Treated with Drug-Eluting Embolic Transarterial Chemoembolization for Hepatocellular Carcinoma.
    Young LB; Tabrizian P; Sung J; Biederman D; Bishay VL; Ranade M; Patel RS; Nowakowski FS; Fischman AM; Lookstein RA; Kim E
    J Vasc Interv Radiol; 2022 May; 33(5):510-517.e1. PubMed ID: 35150838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing various scoring system for predicting overall survival according to treatment modalities in hepatocellular carcinoma focused on Platelet-albumin-bilirubin (PALBI) and albumin-bilirubin (ALBI) grade: A nationwide cohort study.
    Lee SK; Song MJ; Kim SH; Park M
    PLoS One; 2019; 14(5):e0216173. PubMed ID: 31048923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation and Potential of Albumin-Bilirubin Grade and Prognostication in a Nationwide Survey of 46,681 Hepatocellular Carcinoma Patients in Japan: The Need for a More Detailed Evaluation of Hepatic Function.
    Hiraoka A; Michitaka K; Kumada T; Izumi N; Kadoya M; Kokudo N; Kubo S; Matsuyama Y; Nakashima O; Sakamoto M; Takayama T; Kokudo T; Kashiwabara K; Kudo M
    Liver Cancer; 2017 Nov; 6(4):325-336. PubMed ID: 29234636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of modified albumin-bilirubin-TNM score as a prognostic model to evaluate patients with hepatocellular carcinoma.
    Elshaarawy O; Alkhatib A; Elhelbawy M; Gomaa A; Allam N; Alsebaey A; Rewisha E; Waked I
    World J Hepatol; 2019 Jun; 11(6):542-552. PubMed ID: 31293722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.